This article was originally published on TipRanks.com DexCom, Inc.
This article was originally published on TipRanks.com California-based Dexcom (DXCM) is a global medical device company that makes glucose monitoring systems for people …
Shares in Dexcom (DXCM) dropped 9% on Tuesday after the medical device company pre-announced revenue of $500.9M.
Not all stocks are equal. Some will generate returns, while others will harvest losses.
Here’s a glimpse into this hedge fund guru’s Q2 moves that reeled back in three biotech players.
PTCT rises back amid hope for approval in nmDMD; DXCM suffers from new competition in diabetes market.
Canaccord analysts debating the impact of recent events on Zynerba and DexCom.
Investors continue to dump shares of DexCom, Inc. (NASDAQ:DXCM) following the news that competitor Abbott Laboratories (NYSE:ABT) received FDA approval for its FreeStyle …
DexCom, Inc. (NASDAQ:DXCM) shares shot up nearly 5% this afternoon, after Apple CEO Tim Cook revealed that the Apple Watch will be equipped to communicate …
DexCom, Inc. (NASDAQ:DXCM) stock has received a string of buy ratings from analysts following a surprise ruling from the U.
